• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于数据挖掘与生物信息学方法的非酒精性脂肪性肝病中药处方用药规律及作用机制分析

[Analysis on mechanisms and medication rules of herbal prescriptions for nonalcoholic fatty liver disease based on methods of data mining and biological information].

作者信息

Ding Jing, Zhang Bin, Wang Pei-Ji, He Guo-Nong, Wei Dong-Mei, Ding Jia-Lu, Wang Bang-Cai

机构信息

Department of Gastroenterology,Ningbo Hospital of Traditional Chinese Medicine Ningbo 315012,China.

Science and Education Department,Ningbo Hospital of Traditional Chinese Medicine Ningbo 315012,China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2019 Apr;44(8):1689-1695. doi: 10.19540/j.cnki.cjcmm.20190110.001.

DOI:10.19540/j.cnki.cjcmm.20190110.001
PMID:31090336
Abstract

To explore the medication rules of herbal prescriptions for nonalcoholic fatty liver disease,and analyze the possible drug targets and interactions,in order to explore the mechanisms of the herbs. Randomized controlled trials of herbal prescriptions for treating nonalcoholic fatty liver disease were collected from CNKI,Wan Fang,VIP,Sino Med and PubMed databases. The properties,flavors and meridian tropism of herbs were analyzed by using systematic cluster analysis method with SPSS 19. 0 software. Subsequently,the association rules of herbs were analyzed by using Clementine 12. 0 software. Finally,the interactions between targets and relevant signaling pathways were analyzed by Traditional Chinese Medicine Systems Pharmacology Database(TCMSP),Search Tool for the Retrieval of Interacting Genes/Proteins(STRING) and Kyoto Encyclopedia of Genes and Genomes(KEGG). In the 88 prescriptions screened out,the commonly used herbs were Salvia miltiorrhiza,Bupleurum chinense,Alisma orientale,and Crataegus pinnatifida,and the potential signaling pathways were PPAR signaling pathway and calcium signaling pathway. The results showed that the main effects of herbal prescriptions were to improve blood flow/clear blood stasis,clear heatiness/dampness,promote digestion and strengthen spleen. And its mechanism of action may be achieved through the regulation of PPAR signaling pathway and calcium signaling pathway.

摘要

探索非酒精性脂肪性肝病中药方剂的用药规律,分析其可能的药物靶点及相互作用,以探讨中药作用机制。从中国知网、万方、维普、中国生物医学文献数据库及PubMed数据库收集治疗非酒精性脂肪性肝病的中药方剂随机对照试验。运用SPSS 19.0软件的系统聚类分析法分析中药的性味归经。随后,运用Clementine 12.0软件分析中药的关联规则。最后,通过中药系统药理学数据库(TCMSP)、搜索相互作用基因/蛋白质的工具(STRING)和京都基因与基因组百科全书(KEGG)分析靶点与相关信号通路之间的相互作用。在所筛选出的88首方剂中,常用中药有丹参、柴胡、泽泻、山楂,潜在信号通路为PPAR信号通路和钙信号通路。结果表明,中药方剂的主要作用为活血化瘀、清热利湿、消食健脾,其作用机制可能是通过调节PPAR信号通路和钙信号通路来实现的。

相似文献

1
[Analysis on mechanisms and medication rules of herbal prescriptions for nonalcoholic fatty liver disease based on methods of data mining and biological information].基于数据挖掘与生物信息学方法的非酒精性脂肪性肝病中药处方用药规律及作用机制分析
Zhongguo Zhong Yao Za Zhi. 2019 Apr;44(8):1689-1695. doi: 10.19540/j.cnki.cjcmm.20190110.001.
2
[Analysis on medication rules of modern traditional Chinese medicines in treating palpitations based on traditional Chinese medicine inheritance support system].基于中医传承辅助系统的现代中药治疗心悸用药规律分析
Zhongguo Zhong Yao Za Zhi. 2017 Jan;42(2):385-389. doi: 10.19540/j.cnki.cjcmm.20161222.050.
3
[Study on relevance mining of "core drug action target" in Dictionary of Traditional Chinese Medicine Prescriptions].[《中医方剂大辞典》中“核心药物作用靶点”关联挖掘研究]
Zhongguo Zhong Yao Za Zhi. 2018 Oct;43(19):3919-3926. doi: 10.19540/j.cnki.cjcmm.20180710.002.
4
[Medication regularity of combination of traditional Chinese medicine and Western medicine in treating Helicobacter pylori-related gastropathy based on literatures].基于文献的中西医结合治疗幽门螺杆菌相关性胃病的用药规律研究
Zhongguo Zhong Yao Za Zhi. 2019 Nov;44(22):4985-4991. doi: 10.19540/j.cnki.cjcmm.20190401.501.
5
Herbal medicines for fatty liver diseases.用于治疗脂肪肝疾病的草药
Cochrane Database Syst Rev. 2013 Aug 24(8):CD009059. doi: 10.1002/14651858.CD009059.pub2.
6
[Mechanism of Alisma orientale in treating nonalcoholic fatty liver disease].泽泻治疗非酒精性脂肪性肝病的机制
Zhongguo Zhong Yao Za Zhi. 2020 Sep;45(17):4140-4148. doi: 10.19540/j.cnki.cjcmm.20200622.403.
7
[Medication rules of Chinese herbs in treatment of H-type hypertension based on data mining].基于数据挖掘的中药治疗H型高血压用药规律研究
Zhongguo Zhong Yao Za Zhi. 2024 May;49(9):2522-2531. doi: 10.19540/j.cnki.cjcmm.20240117.501.
8
[Analysis of on medication rules for Qi-deficiency and blood-stasis syndrome of chronic heart failure based on data mining technology].基于数据挖掘技术的慢性心力衰竭气虚血瘀证用药规律分析
Zhongguo Zhong Yao Za Zhi. 2017 Jan;42(1):182-186. doi: 10.19540/j.cnki.cjcmm.20161222.040.
9
[Analysis on mechanisms and medication rules of herbal prescriptions for gout caused by heat-damp accumulation syndrome based on data mining and network pharmacology].基于数据挖掘和网络药理学的湿热蕴结证痛风中药方剂作用机制及用药规律分析
Zhongguo Zhong Yao Za Zhi. 2018 Jul;43(13):2824-2830. doi: 10.19540/j.cnki.cjcmm.20180327.006.
10
Analysis of Herbal Mechanisms and Prescriptions for Chronic Cerebral Circulatory Insufficiency Based on Data Mining and Network Pharmacology.基于数据挖掘和网络药理学的慢性脑循环功能不全的草药机制和处方分析。
Comb Chem High Throughput Screen. 2022;25(8):1239-1253. doi: 10.2174/1386207324999210120194312.

引用本文的文献

1
Potential of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease: A promising future.中药在治疗非酒精性脂肪性肝病中的潜力:前景广阔。
World J Gastroenterol. 2024 Nov 21;30(43):4597-4601. doi: 10.3748/wjg.v30.i43.4597.
2
Effects of extract on metabolic dysfunction-associated fatty liver disease the FXR/PPARα-SREBPs pathway.提取物对代谢功能障碍相关脂肪性肝病的影响:FXR/PPARα-SREBPs途径
Front Pharmacol. 2022 Oct 5;13:1007274. doi: 10.3389/fphar.2022.1007274. eCollection 2022.
3
Pharmacological effects of Chinese medicine modulating NLRP3 inflammasomes in fatty liver treatment.
中药调节NLRP3炎性小体在脂肪肝治疗中的药理作用。
Front Pharmacol. 2022 Sep 8;13:967594. doi: 10.3389/fphar.2022.967594. eCollection 2022.
4
Protective Effect of Decoction Against Non-Alcoholic Fatty Liver Disease Through Inhibition of ROS/NLRP3/IL-1β Pathway by Nrf2 Signaling Activation.通过激活Nrf2信号通路抑制ROS/NLRP3/IL-1β途径,汤剂对非酒精性脂肪性肝病的保护作用
Front Pharmacol. 2022 Jun 21;13:877924. doi: 10.3389/fphar.2022.877924. eCollection 2022.
5
Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives.中医在非酒精性脂肪性肝病中的应用:分子机制与治疗前景
Chin Med. 2021 Aug 3;16(1):68. doi: 10.1186/s13020-021-00469-4.
6
Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment.药物重定位方法、潜在药物和用于 COVID-19 治疗的新型药物靶点。
J Environ Public Health. 2021 Apr 22;2021:6631721. doi: 10.1155/2021/6631721. eCollection 2021.
7
A Recent Achievement in the Discovery and Development of Vaccines and Therapeutic Agents in the Race for COVID-19 Protection and Treatment.在新冠病毒保护和治疗的竞赛中,疫苗和治疗药物研发的最新成果。
J Evid Based Integr Med. 2021 Jan-Dec;26:2515690X211003727. doi: 10.1177/2515690X211003727.
8
Herbal Medicine in the Treatment of Non-Alcoholic Fatty Liver Diseases-Efficacy, Action Mechanism, and Clinical Application.草药医学治疗非酒精性脂肪性肝病——疗效、作用机制及临床应用
Front Pharmacol. 2020 May 12;11:601. doi: 10.3389/fphar.2020.00601. eCollection 2020.